Overview
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
Status:
Completed
Completed
Trial end date:
2019-12-31
2019-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
To investigate the effect of cilostazol compared with aspirin on carotid atherosclerosis in patients with type 2 diabetes mellitusPhase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Seoul National University Bundang HospitalTreatments:
Aspirin
Cilostazol
Phosphodiesterase 3 Inhibitors
Criteria
Inclusion Criteria:- Age between 30 and 80 years
- Patients with type 2 diabetes on treatment (HbA1c 6.0-11.0%)
- Carotid plaque on 3D ultrasound
Exclusion Criteria:
- Acute bleeding or bleeding tendency
- Diagnosed with heart failure
- Suggestive of ischemia on ECG
- Uncontrolled hypertension
- Recently diagnosed with peptic ulcer disease
- Taking other antiplatelet agents
- Hypersensitivity to salicylic acid
- Aspirin induced asthma
- Severe kidney, liver, heart disease